P1379: OPTIMIZATION OF FLUDARABINE PHARMACOKINCETICS TO REDUCE THE RELAPSE INCIDENCE IN AML PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

• T. Thavayogarajah,
• G. Nair,
• S. Balabanov,
• M. G. Manz,
• D. Müller,
• U. Schanz

Affiliations

T. Thavayogarajah

1 Department of Medical Oncology and Hematology

G. Nair

1 Department of Medical Oncology and Hematology

S. Balabanov

1 Department of Medical Oncology and Hematology

M. G. Manz

1 Department of Medical Oncology and Hematology

D. Müller

2 Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland

U. Schanz

1 Department of Medical Oncology and Hematology